Patient
Resources
At the core of our mission is a belief that immunotherapy should work for everyone. That’s why we’re here to share knowledge and provide insight into our immunotherapy research.
Questions About Patient Access?
Agenus is committed to making our therapies available to patients with cancer based upon advice of the treating physician. Our goal is to provide access to our investigational medicines at the appropriate time and in the correct manner for patients.
About Immunotherapy
Immunotherapy is a transformative approach that is helping to redefine what’s possible in cancer care, offering new hope and better outcomes for patients across many cancer types.
BOT + BAL
Bringing the Power of Immunotherapy to More Patients
BOT/BAL—Botensilimab (BOT) plus Balstilimab (BAL)—represents the next generation of immunotherapy, designed to help more patients benefit from the body’s own defenses against cancer.
BAL, balstilimab; BOT, botensilimab; MSS, microsatellite stable. 1. Kasi P, et al. Oral presentation at the ESMO Gastrointestinal Cancers Congress. Munich, Germany. 2024. Presentation #743. 2. Chalabi M, et al. Oral presentation as AACR. Chicago, IL, USA. 2025. Abstract #CT130.
Ask Us Anything
Get answers about clinical trials, patient access, and more from medical experts.
Patient Advocacy Groups
Navigating the world of cancer is complex. Below are links to resources that you may find helpful for seeking additional information, connecting with supportive communities, and deepening your understanding of your care options.
